AEON Biopharma, Inc. (AEON) vs Aspire Biopharma Holdings, Inc. (ASBP)
AEON Biopharma, Inc. and Aspire Biopharma Holdings, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Aspire Biopharma Holdings, Inc. are of similar size ($12.7M and $12.2M). AEON Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire Biopharma Holdings, Inc. trades at 0.2×. AEON Biopharma, Inc. has the higher net margin (0.00% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, AEON Biopharma, Inc. leads on 6 and Aspire Biopharma Holdings, Inc. on 4.
Valuation
Profitability
| Metric | AEON | ASBP | Biotechnology median |
|---|---|---|---|
| Gross margin | — | (24.97%) | 65.16% |
| Operating margin | 0.00% | (7,491.61%) | 0.00% |
| Net margin | 0.00% | (11,309.31%) | 0.00% |
| Free cash flow margin | 0.00% | (7,355.07%) | 0.00% |
| Return on equity | 350.00% | (1,032.15%) | (57.72%) |
| Return on assets | (621.70%) | (152.09%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack